Kartik Kiran Shah
Fondateur chez Oxeia Biopharmaceuticals, Inc.
Profil
Kartik Kiran Shah is the founder of Oxeia Biopharmaceuticals, Inc. (founded in 2014) where he holds the title of Director.
He is currently the Chairman-Trustees Board at Global X Funds.
In his former positions, he served as Director-Consulting & Product Management at Wireless Generation, Inc., Manager at Amgen, Inc., Principal at Medtronic, Inc., Vice President-Business Development at LungLife AI, Inc., and Management Consultant at Oliver, Wyman & Co. LLC.
Mr. Shah obtained his undergraduate degree from the University of Pennsylvania and his MBA from Harvard Business School.
Postes actifs de Kartik Kiran Shah
| Sociétés | Poste | Début |
|---|---|---|
| Global X Funds | Directeur/Membre du Conseil | - |
Oxeia Biopharmaceuticals, Inc.
 Oxeia Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Oxeia Biopharmaceuticals, Inc. is a clinical-stage biotech company, which develops new, innovative therapies for conditions that are defined by deficits in neurocognition from injury, degeneration and aging. Its two indications are for (i) mild traumatic brain injury (?mTB?) known as concussion, and (ii) the cognitive decline, lethargy and ?brain-fog? associated with Covid-19 infection, known as Covid Longhauler syndrome (?Long Covid?). The company was founded in 2014 by Vishal Bansal, Amit Dilip Munshi & Kartik Kiran Shah and is headquartered in Boston, MA. | Fondateur | 01/01/2014 |
Anciens postes connus de Kartik Kiran Shah
| Sociétés | Poste | Fin |
|---|---|---|
| AMGEN INC. | Corporate Officer/Principal | - |
Medtronic, Inc.
 Medtronic, Inc. Medical SpecialtiesHealth Technology Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN. | Corporate Officer/Principal | - |
Wireless Generation, Inc.
 Wireless Generation, Inc. Packaged SoftwareTechnology Services Wireless Generation develops software tools, systems and services for teachers. It offers technology that analyzes student data and provides curriculum customized to individual learning needs. The company also builds large-scale data systems, such as New York City's ARIS, that centralize student data and give educators and parents visibility into learning | Corporate Officer/Principal | - |
| Oliver, Wyman & Co. LLC | Corporate Officer/Principal | - |
| LUNGLIFE AI, INC. | Corporate Officer/Principal | - |
Formation de Kartik Kiran Shah
| Harvard Business School | Masters Business Admin |
| University of Pennsylvania | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| LUNGLIFE AI, INC. | Health Services |
| AMGEN INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
| Global X Funds | Miscellaneous |
Wireless Generation, Inc.
Wireless Generation, Inc. Packaged SoftwareTechnology Services Wireless Generation develops software tools, systems and services for teachers. It offers technology that analyzes student data and provides curriculum customized to individual learning needs. The company also builds large-scale data systems, such as New York City's ARIS, that centralize student data and give educators and parents visibility into learning | Technology Services |
| Oliver, Wyman & Co. LLC | |
Medtronic, Inc.
Medtronic, Inc. Medical SpecialtiesHealth Technology Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN. | Health Technology |
Oxeia Biopharmaceuticals, Inc.
Oxeia Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Oxeia Biopharmaceuticals, Inc. is a clinical-stage biotech company, which develops new, innovative therapies for conditions that are defined by deficits in neurocognition from injury, degeneration and aging. Its two indications are for (i) mild traumatic brain injury (?mTB?) known as concussion, and (ii) the cognitive decline, lethargy and ?brain-fog? associated with Covid-19 infection, known as Covid Longhauler syndrome (?Long Covid?). The company was founded in 2014 by Vishal Bansal, Amit Dilip Munshi & Kartik Kiran Shah and is headquartered in Boston, MA. | Health Technology |
